Continuous regional arterial infusion with fluorouracil and octreotide attenuates severe acute pancreatitis in a canine model

PLoS ONE

Volumn 7, Issue 5, 2012, Pages

  Zhou, Meng Tao ^a   Chen, Bi Cheng ^a   Sun, Hong Wei ^a   Jin, Yue Peng ^a   Yang, Fa Jing ^a   Zhang, Xing ^a   Andersson, Roland ^b   Zhang, Qi Yu ^a  

^a WENZHOU MEDICAL UNIVERSITY   (China)

^b LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLASE; CEPHALOSPORIN; FLUOROURACIL; METRONIDAZOLE; OCTREOTIDE; THROMBOXANE B2; TUMOR NECROSIS FACTOR ALPHA; UREA; ANTIMETABOLITE; CREATININE; GASTROINTESTINAL AGENT;

ACUTE PANCREATITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTINUOUS INFUSION; CONTINUOUS REGIONAL ARTERIAL INFUSION THERAPY; CONTROLLED STUDY; DISEASE SEVERITY; DOG; DRUG ACTIVITY; DRUG ADMINISTRATION; DRUG EFFICACY; DRUG SAFETY; FEMALE; HISTOPATHOLOGY; INFECTION; INFECTION PREVENTION; MALE; NONHUMAN; PROTEIN BLOOD LEVEL; SURVIVAL TIME; TREATMENT RESPONSE; ANIMAL; BLOOD; DRUG EFFECT; INTRAARTERIAL DRUG ADMINISTRATION; KIDNEY; PANCREAS; PANCREATITIS; PATHOLOGY;

ANIMALIA;

AMYLASES; ANIMALS; ANTIMETABOLITES; CREATININE; DOGS; FEMALE; FLUOROURACIL; GASTROINTESTINAL AGENTS; INFUSIONS, INTRA-ARTERIAL; KIDNEY; MALE; OCTREOTIDE; PANCREAS; PANCREATITIS; THROMBOXANE B2; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84861386855     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0037347     Document Type: Article

References (42)

1. Bai Y, Liu Y, Jia L, Jiang H, Ji M, et al. (2007) Severe acute pancreatitis in China: etiology and mortality in 1976 patients. Pancreas 35: 232-237.
2. Gultekin FA, Kerem M, Tatlicioglu E, Aricioglu A, Unsal C, et al. (2007) Leptin treatment ameliorates acute lung injury in rats with cerulein-induced acute pancreatitis. World J Gastroenterol 13: 2932-2938.
3. Al Mofleh IA, (2008) Severe acute pancreatitis: pathogenetic aspects and prognostic factors. World J Gastroenterol 14: 675-684.
4. Hukkanen RR, Liggitt HD, Murnane RD, Frevert CW, (2009) Systemic inflammatory response syndrome in nonhuman primates culminating in multiple organ failure, acute lung injury, and disseminated intravascular coagulation. Toxicol Pathol 37: 799-804.
5. Zhou MT, Chen CS, Chen BC, Zhang QY, Andersson R, (2010) Acute lung injury and ARDS in acute pancreatitis: mechanisms and potential intervention. World J Gastroenterol 16: 2094-2099.
6. Zhou M, Chen B, Sun H, Deng Z, Andersson R, et al. (2011) The protective effects of Lipoxin A4 during the early phase of severe acute pancreatitis in rats. Scand J Gastroenterol 46: 211-219.
7. Barreto SG, Carati CJ, Schloithe AC, Toouli J, Saccone GT, (2010) Octreotide negates the benefit of galantide when used in the treatment of caerulein-induced acute pancreatitis in mice. HPB (Oxford) 12: 403-411.
8. Tian H, Zhang X, Wu C, Chen L, Ying R, et al. (2009) Effects of Baicalin and Octreotide on the serum TNF-alpha level and apoptosis in multiple organs of rats with severe acute pancreatitis. Inflammation 32: 191-201.
9. Guler O, Akturan S, Kisli E, Dolapci I, Caydere M, et al. (2009) Acute pancreatitis, bacterial translocation, and different octreotide regimens: an experimental study. Surg Today 39: 876-883.
10. Woeste G, Wullstein C, Meyer S, Usadel KH, Hopt UT, et al. (2008) Octreotide attenuates impaired microcirculation in postischemic pancreatitis when administered before induction of ischemia. Transplantation 86: 961-967.
11. Paran H, Mayo A, Paran D, Neufeld D, Shwartz I, et al. (2000) Octreotide treatment in patients with severe acute pancreatitis. Dig Dis Sci 45: 2247-2251.
12. Gu F, Liu Y, Pan R, (1995) Local arterial infusion of 5-FU in treatment of acute necrotic pancreatitis. Zhonghua Wai Ke Za Zhi 33: 339-341.
13. Chen BQ ZN LC, Fan W, Hao HS, Zhang Z, (2006) The immune mechanism of 5-fluorouracil in the protection of kidney from injury of severe acute pancreatitis. Chinese Journal of Current Advances in General Surgery 9: 215-217.
14. Mikami Y, Takeda K, Matsuda K, Qiu-Feng H, Fukuyama S, et al. (2005) Rat experimental model of continuous regional arterial infusion of protease inhibitor and its effects on severe acute pancreatitis. Pancreas 30: 248-253.
15. Aho HJ, Koskensalo SM, Nevalainen TJ, (1980) Experimental pancreatitis in the rat. Sodium taurocholate-induced acute haemorrhagic pancreatitis. Scand J Gastroenterol 15: 411-416.
16. ZC ZS, (1991) The process in the treatment of acute necrotizing pancreatitis in surgery. Chinese Journal of Practical Surgery Z1: 466-469.
17. Schmidt J, Rattner DW, Lewandrowski K, Compton CC, Mandavilli U, et al. (1992) A better model of acute pancreatitis for evaluating therapy. Ann Surg 215: 44-56.
18. Zhang XP, Zhang L, Wang Y, Cheng QH, Wang JM, et al. (2007) Study of the protective effects of dexamethasone on multiple organ injury in rats with severe acute pancreatitis. JOP 8: 400-412.
19. Zhang XP, Zhang L, Yang P, Zhang RP, Cheng QH, (2008) Protective effects of baicalin and octreotide on multiple organ injury in severe acute pancreatitis. Dig Dis Sci 53: 581-591.
20. Omata F, Deshpande G, Tokuda Y, Takahashi O, Ohde S, et al. (2010) Meta-analysis: somatostatin or its long-acting analogue, octreotide, for prophylaxis against post-ERCP pancreatitis. J Gastroenterol 45: 885-895.
21. Inoue K, Hirota M, Kimura Y, Kuwata K, Ohmuraya M, et al. (2003) Further evidence for endothelin as an important mediator of pancreatic and intestinal ischemia in severe acute pancreatitis. Pancreas 26: 218-223.
22. Takeda K, Mikami Y, Fukuyama S, Egawa S, Sunamura M, et al. (2005) Pancreatic ischemia associated with vasospasm in the early phase of human acute necrotizing pancreatitis. Pancreas 30: 40-49.
23. Zhao Yupei HY, Tao Wei, Cai Lixing, Zhu Yu, (2001) Difference of distribution of epirubicin between plasma and pancreatic tissue of rats under different route. Chinese Journal of Experimental Surgery 18: 54-55.
24. Hayashi J, Kawarada Y, Isaji S, Yokoi H, Higashiguchi T, (1996) Therapeutic effects of continuous intraarterial antibiotic infusion in preventing pancreatic infection in experimental acute necrotizing pancreatitis. Pancreas 13: 184-192.
25. Zhang XP, Tian H, Lai YH, Chen L, Zhang L, et al. (2007) Protective effects and mechanisms of Baicalin and octreotide on renal injury of rats with severe acute pancreatitis. World J Gastroenterol 13: 5079-5089.
26. Zhang XP, Zhang J, Ren Z, Feng GH, Zhu W, et al. (2008) Study on protecting effects of baicalin and octreotide on hepatic injury in rats with severe acute pancreatitis. World J Gastroenterol 14: 6551-6559.
27. Coelho AM, Machado MC, Cunha JE, Sampietre SN, Abdo EE, (2003) Influence of pancreatic enzyme content on experimental acute pancreatitis. Pancreas 26: 230-234.
28. Kakugawa Y, Takeda K, Sunamura M, Kawaguchi S, Kobari M, et al. (1990) [Effect of continuous arterial infusion of protease inhibitor on experimental acute pancreatitis induced by closed duodenal loop obstruction]. Nihon Shokakibyo Gakkai Zasshi 87: 1444-1450.
29. Satoh H, Harada M, Tashiro S, Shiroya T, Imawaka H, et al. (2004) The effect of continuous arterial infusion of gabexate mesilate (FOY-007) on experimental acute pancreatitis. J Med Invest 51: 186-193.
30. Imaizumi H, Kida M, Nishimaki H, Okuno J, Kataoka Y, et al. (2004) Efficacy of continuous regional arterial infusion of a protease inhibitor and antibiotic for severe acute pancreatitis in patients admitted to an intensive care unit. Pancreas 28: 369-373.
31. Takeda K, Matsuno S, Ogawa M, Watanabe S, Atomi Y, (2001) Continuous regional arterial infusion (CRAI) therapy reduces the mortality rate of acute necrotizing pancreatitis: results of a cooperative survey in Japan. J Hepatobiliary Pancreat Surg 8: 216-220.
32. Johnson RM, Barone RM, Newson BL, Das Gupta TK, Nyhus LM, (1973) Treatment of experimental acute pancreatitis with 5-flourouracil (5-FU). Am J Surg 125: 211-222.
33. Kinami Y, Miyazaki I, Kawamura M, Sugii M, Sakane Y, (1976) Clinical effects of anticancer drugs to pancreatic diseases as protein synthesis inhibitors. Gastroenterol Jpn 11: 123-132.
34. Mironov VI, Zabrodina LV, (1985) Cumulation of 5-fluorouracil induced by an electric field in the treatment of acute experimental pancreatitis pp. 168-170.
35. Bielecki K, Wiedmann M, Meyer F, Kimura W, Mossner J, (1994) Effect of 5-fluorouracil on secretion and synthesis of pancreatic digestive enzymes: studies in isolated pancreatic acini and perfused pancreas derived from normal rats and from rats with acute necrotizing pancreatitis. Pancreas 9: 518-525.
36. Castellanos J, Manifacio G, Toledo-Pereyra LH, Shatney CH, Lillehei RC, (1975) Consistent protection from pancreatitis in canine pancreas allografts treated with 5-fluorouracil. J Surg Res 18: 305-311.
37. Mann SK, Mann NS, (1979) Effect of chlorophyll-a, fluorouracil, and pituitrin on experimental acute pancreatitis. Arch Pathol Lab Med 103: 79-81.
38. Chen XL, Ciren SZ, Zhang H, Duan LG, Wesley AJ, (2009) Effect of 5-FU on modulation of disarrangement of immune-associated cytokines in experimental acute pancreatitis. World J Gastroenterol 15: 2032-2037.
39. Laptev VV, (1981) 5-fluorouracil treatment of destructive pancreatitis. Khirurgiia (Mosk) 67-73.
40. Saario IA, (1983) 5-Fluorouracil in the treatment of acute pancreatitis. Am J Surg 145: 349-352.
41. Van Ooijen B, Ouwendijk RJ, Kort WJ, Zijlstra FJ, Vincent JE, et al. (1988) Raised plasma thromboxane B2 levels in experimental acute necrotizing pancreatitis in rats. The effects of flunarizine, dazoxiben, and indomethacin. Scand J Gastroenterol 23: 188-192.
42. Andersson B, Olin H, Eckerwall G, Andersson R, (2006) Severe acute pancreatitis-outcome following a primarily non-surgical regime. Pancreatology 6: 536-541.